S&P・Nasdaq 本質的価値 お問い合わせ

Alpha Tau Medical Ltd. DRTSW NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • IL • USD

SharesGrow Score
40/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Alpha Tau Medical Ltd. (DRTSW) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

アナリスト予想 一株当たり利益(EPS) $-0.45 および 売上高 $0.00B 来期予想.

一株当たり利益(EPS)実績推移: 2024: 実績 $-0.45 vs 予想 $-0.45 (上回る +0%). 2025: 実績 $-0.53 vs 予想 $-0.51 (下回る -3.8%). アナリスト精度: 98%.

EPS予測 — DRTSW

98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual –$0.45 vs Est –$0.45 ▼ 0.0% off
2025 Actual –$0.53 vs Est –$0.51 ▼ 3.7% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

売上高予測 — DRTSW

Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る